Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3294283 | Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure | NOVARTIS AG | Dec 8, 2023 |
EP3113774 | Compositions Of Grapiprant And Methods For Using The Same | ARATANA THERAPEUTICS INC. | Sep 21, 2022 |
EP2922526 | Manufacturing Of Semi-Plastic Pharmaceutical Dosage Units | INTERVET INTERNATIONAL B.V. | Jul 26, 2022 |
EP2863895 | Tablet Formulation Comprising A Peptide And A Delivery Agent | NOVO NORDISK A/S | Jan 14, 2022 |
EP3173071 | Maropitant Formulation | LE VET B.V. | Dec 23, 2021 |
EP2478907 | Methods And Compositions For Treating Cancer | COUGAR BIOTECHNOLOGY, INC. | Dec 22, 2021 |
EP3061454 | Parasiticidal Oral Veterinary Compositions Comprising Systemically-Acting Active Agents, Methods And Uses Thereof | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. | Dec 9, 2021 |
EP2925324 | Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia | RICHTER GEDEON NYRT. | Sep 30, 2021 |
EP2340828 | Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor | NOVARTIS AG | Apr 15, 2021 |
EP2359815 | Compositions Comprising Amlodipine And Bisoprolol | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MÜKÖDÖ RÉSZVÉNYTÁRSASÁG | Oct 8, 2020 |
Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP2459555 | Nov 3, 2021 | Processes For Crystallization Of Rivaroxaban | 1 |
Feel free to send us a message here and we will get back to you